The latest development in the Pradaxa multidistrict litigation (MDL) in the U.S. District Court for the Southern District of Illinois involves a recently filed court document from mid-September. Both parties…
Read More
A plaintiff in a Pradaxa bleeding risk lawsuit was recently granted approval to move forward with his suit. In the Pradaxa lawsuit, the plaintiff claims that the pharmaceutical company behind…
Read More
Published September 11, 2012 on Carey & Danis In the lawsuit, Easterling v. Collecto, Inc., a judge ruled last month that the debt collection company based in Massachusetts known as…
Read More
A new pretrial order document has been filed in two of the six transvaginal mesh multidistrict litigations (MDLs) in a federal court in West Virginia. Filed in the Ethicon MDL…
Read More
In a federal court in West Virginia, five transvaginal mesh manufacturers, C. R. Bard, Boston Scientific Corp., American Medical Systems, Coloplast Corp., and Cook Medical, are purported to be in…
Read More
A state case regarding the recalled DePuy ASR hip replacement system is scheduled to go to trial in January 2013 in Prince George's County, Maryland. If DePuy does not settle…
Read More
The parties involved in the Ethicon multidistrict litigation (MDL) in the U.S. District Court for the Southern District of West Virginia are facing difficulty regarding discovery requests, according to a…
Read More
Federal Judge Overseeing Ethicon Transvaginal Mesh Lawsuits Levies Sanctions Against Defense Counsel
Published May 16, 2014 by Digital Journal The federal judge overseeing thousands of transvaginal mesh lawsuits filed against Johnson & Johnson's Ethicon, Inc. unit has sanctioned the companies' attorneys for…
Read More
This month, Carey & Danis provided news on the widely reported DePuy settlement of $4 billion. The latest development to surface from the DePuy ASR settlement is that DePuy has…
Read More
The St. Louis class action attorneys at Carey & Danis have been closely following the DePuy ASR settlement following the announcement of Johnson & Johnson and DePuy's $2.5 billion deal.…
Read More